Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

746
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
746
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

511
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
511

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Epidemiology of medical emergency team calls in patients undergoing lung transplantation.

JHLT open·2026
Same author

Perceptions of end-of-life care quality among bereaved closest contacts of community-dwelling older Australians: a cross-sectional survey of the ASPREE cohort.

Research square·2026
Same author

Metabolomic signatures prior to in-hospital cardiac arrest: insights into potential therapeutic targets.

Scientific reports·2026
Same author

Percutaneous dilatational tracheostomy in critical illness: A practice survey of intensivists in Australia and New Zealand.

Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine·2026
Same author

Prevalence and characteristics of intensive care unit follow-up services in Australia and New Zealand: A binational survey.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2026
Same author

Socioeconomic disadvantage and sepsis survival in Australian intensive care units: A retrospective cohort study.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Marwan N Sabbagh1, Daryl Jones2, Jo Vandercappellen2

  • 1Barrow Neurological Institute, Phoenix, AZ, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

准确的阿尔茨海默病诊断对于新疗法至关重要. 这项研究将基于血液的生物标志物 (BBM) 与标准护理进行比较,评估诊断时间表和患者对痴呆症确认的旅程.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

699

科学领域:

  • 神经学 神经学
  • 生物标志物发现发现
  • 诊断医学 诊断医学 诊断医学

背景情况:

  • 全球范围内不被发现的痴呆症的高发病率需要及时诊断才能有效治疗阿尔茨海默病 (AD).
  • 新兴的基于血液的生物标志物 (BBM) 显示出准确的粉样蛋白病理确认的希望,满足严格的性能标准.
  • 这项研究解决了在新的抗粉样蛋白疗法时代需要有效的诊断途径的需求.

研究的目的:

  • 分析使用新型BBM和当前护理标准 (SOC) 生物标志物的最终生物标志物确认诊断的时间.
  • 评估6个月内接受BBM确认诊断的患者的覆盖范围和代表性.
  • 通过不同的测试方式来评估诊断所需的患者访问次数.

主要方法:

  • 一项前性观察性研究,从美国三个地区的电子医疗记录中收集二次数据.
  • 招募最多180名年龄≥55岁的患者,怀疑或可能患有AD和渐进性认知衰退.
  • 认知评估,实验室测试,成像,患者特征,诊断程序和不良事件的描述性分析.

主要成果:

  • 已经招募了三家记忆护理诊所,计划招收多达180名患者.
  • 数据收集将包括诊断测试类型,访问次数,诊断时间和不良事件.
  • 该研究旨在进行描述性分析,以描述诊断过程.

结论:

  • 该研究将确定BBM和当前SOC生物标志物的最终生物标志物确认诊断的时间.
  • 这些发现将照亮阿尔茨海默病患者的诊断过程,并可能展示BBM的好处.
  • 这项研究支持AD诊断的不断变化的格局,强调可访问和可扩展的生物标志物解决方案.